What is a custom viral vector? Our custom viral services are highlighted by a consistent high titer and large delivery viral counts. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This process can be performed inside a living organism ( in vivo) or in cell culture ( in vitro ).Are viral vectors the future of manufacturing? The promising results from clinical studies of the use of viral vectors to address important medical needs, have surged the interest in developing scalable and cost-efficient manufacturing processes. For gene therapy alone, the global market value is estimated to exceed 10 billion USD by 2025 (2).Where are the raav viral vectors made? We specialize in the production of rAAV viral vectors. Our optimized facility in San Sebastian, Spain maximizes throughput and efficiency of our proprietary Pro10™ suspension manufacturing platform. This enables industry-leading scalability, reproducibility, and speed to market.What are viral vectors used for in gene therapy? In gene therapy, viral vectors can be used for delivery of functional genes to replace defective genes to cure genetic disorders. As a vaccine platform, viral vectors can be used for expression and presentation of pathogenic antigens to induce an immune response by mimicking a natural infection.
Viralgen Vector Core Unique center in Europe for the production of viral vectors Together with the US Company, Asklepios Biopharmaceutical Inc (Askbio), Columbus is developing a production facility of adeno-associated viruses (AAV) that is located in the Science and Technology Park of Gipuzkoa, in San Sebastián.
ABOUT US; HOW TO SUBSCRIBE ABOUT US; HOW TO SUBSCRIBE; REQUEST LISTING; Viralgen Vector Core SL Spain. Viralgen provides an integrated set of development, manufacturing and testing services and the capacity required for clinical and commercial AAV vector manufacturing. Private/Public: private Phone: +34 943 47 77 33 Email: [email ...
Find company research, competitor information, contact details & financial data for VIRALGEN COMMERCIAL THERAPEUTIC VECTOR CORE SL. of DONOSTIA/SAN SEBASTIAN. Get the latest business insights from Dun & Bradstreet.
About us. Viralgen Vector Core becomes the convergence point from experienced specialized organizations in biotechnology and life science fields, united with the aim of creating a ...
Company Description: VIRALGEN VECTOR CORE SL. is located in DONOSTIA/SAN SEBASTIAN, Spain and is part of the Scientific Research and Development Services Industry. VIRALGEN VECTOR CORE SL. has 120 employees at this location and generates $22.86 million in sales (USD). (Employees figure is estimated).
Viralgen Vector Core has licensed the Pro10™ cell line and manufacturing process from Askbio. Pro10™ cell line is derived from HEK293 cells and show high yields across a wide range of serotypes, multiple chimeric, and novel capsids. ...
Viralgen is a CDMO born as a joint venture between Askbio and Columbus Venture Partners, combining decades of technology and drug development experience in multiple platforms to support best-in-class service offerings to the gene therapy market. Viralgen was created in 2017 in response to the unmet need for manufacturing of gene therapies.
Gene therapy is an exciting, dynamic industry and our focus is on helping you succeed. Our goal is to put structures in place that enable open collaboration and quick adaptation to the needs of the project, whether it be timelines, cost, regulatory or clinical changes. Therapeutic plasmid T rans f er & A A V se r o type selection Titer
Viralgen Vector Core Information. Founded in 2017 as a joint venture between AskBio and Columbus Venture Partners (a Spanish venture capital group), Viralgen is a world-class AAV cGMP. Viralgen licenses AskBio's Pro10™ cell line technology that allows for greater scale, higher yields and increased accuracy of AAV therapeutics.
Traditional pharmaceutical based treatments typically modify components of the cell or its environment to induce a therapeutic response. Gene therapy, on the other hand, is focused on utilizing viral-based technologies that deliver therapeutic genes to human cells or tissues to correct the genetic defect directly.
Our facilities. Parque Científico y Tecnológico de Gipuzkoa, Paseo Mikeletegi 83, 20009 San Sebastián, Spain. Tel: +34 943 47 77 33. [email protected]. Press contact: [email protected].
In total it has 14 registered charges. Its latest announcement in the Borme was published on 25/02/2021 and its most recent filing of ordinary annual accounts was for 2019. You can consult the contact details for VIRALGEN VECTOR CORE SL, including its telephone number, address and website, in the Company Details module.